Dual effects of mefenamic acid on the I Ks molecular complex
British Journal of Pharmacology · 2025
DOI: 10.1111/bph.17389 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Pharmacology, 2025. Verfasst von Magnus Chan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada. Hauptthemen laut MEDLINE: Mefenamic Acid, Potassium Channels, Voltage-Gated, KCNQ1 Potassium Channel. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CIHR, Volkswagen Foundation, Heart and Stroke Foundation of Canada.
Abstract (Originalsprache)
Background and Purpose Mutations in both KCNQ1 and KCNE1, which together form the cardiac I Ks current, are associated with inherited conditions such as long and short QT syndromes. Mefenamic acid, a non‐steroidal anti‐inflammatory drug, is an I Ks potentiator and may be utilised as an archetype to design therapeutically useful I Ks agonists. However, here we show that mefenamic acid can also act as an I Ks inhibitor, and our data reveal its dual effects on KCNQ1/KCNE1 channels. Experimental Approach Effects of mefenamic acid on wild type (WT) and mutant KCNQ1/KCNE1 channels expressed in tsA201 cells were studied using whole cell patch clamp. Molecular dynamics simulations were used to determine trajectory clustering. Key Results Mefenamic acid inhibits WT I Ks at high concentrations while preserving some attributes of current potentiation. Inhibitory actions of mefenamic acid are unmasked at lower drug concentrations by KCNE1 and KCNQ1 mutations in the mefenamic acid binding pocket, at the extracellular end of KCNE1 and in the KCNQ1 S6 helix. Mefenamic acid does not inhibit KCNQ1 in the absence of KCNE1 but inhibits I Ks current in a concentration‐dependent manner in the mutant channels. Inhibition involves modulation of pore kinetics and/or voltage sensor domain‐pore coupling in WT and in the KCNE1 E43C mutant. Conclusion and Implications This work highlights the importance of structural motifs at the extracellular inter‐subunit interface of KCNQ1 and KCNE1 channels, and their interactions, in determining the nature of drug effects on the I Ks channel complex and has important implications for treating patients with specific long QT mutations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada.
- Laboratory of Computational Modeling of Biological Processes, Institute of Molecular Biology, Yerevan, Armenia.
- Currently at National Center for Biotechnology Information, National Library of Medicine, National Institutes for Health, Bethesda, Maryland, USA.
- Molecular Neuroscience Group, Institute of Molecular Biology, Yerevan, Armenia.
ORCID-Profile: David Fedida
Förderung
- CIHR
- Volkswagen Foundation
- Heart and Stroke Foundation of Canada
- Natural Sciences and Engineering Research Council of Canada
- Canadian Institutes of Health Research
Zitieren
APA
Chan, M., Pourrier, M., Eldstrom, J., Sahakyan, H., Vardanyan, V., & Fedida, D. (2025). Dual effects of mefenamic acid on the I Ks molecular complex. British Journal of Pharmacology. https://doi.org/10.1111/bph.17389
Vancouver
Chan M, Pourrier M, Eldstrom J, Sahakyan H, Vardanyan V, Fedida D. Dual effects of mefenamic acid on the I Ks molecular complex. British Journal of Pharmacology. 2025. doi:10.1111/bph.17389
BibTeX
@article{Chan2025,
author = {Chan, Magnus and Pourrier, Marc and Eldstrom, Jodene and Sahakyan, Harutyun and Vardanyan, Vitya and Fedida, David},
title = {Dual effects of mefenamic acid on the I Ks molecular complex},
journal = {British Journal of Pharmacology},
year = {2025},
doi = {10.1111/bph.17389}
}
EUVIMED